Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
JP Morgan Chase
New York
| $270M | +$25.4M | 22 | 0.07% | Increased |
|
| 27 |
Manning & Napier Advisors
Fairport,
New York
| $264M | +$9.94M | 1 | 1.53% | Increased |
|
| 28 |
Bank of New York Mellon
New York
| $247M | +$3.13M | 31 | 0.07% | Increased |
|
| 29 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $246M | +$39.7M | 1 | 2.85% | Increased |
|
| 30 |
Goldman Sachs
New York
| $235M | +$24.1M | 26 | 0.08% | Increased |
|
| 31 |
Capital World Investors
Los Angeles,
California
| $227M | +$25.6M | 3 | 0.06% | Increased |
|
| 32 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $215M | +$7.12M | 2 | 0.38% | Increased |
|
| 33 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
| $208M | $0 | 1 | 22.75% | Maintained |
|
| 34 |
Janus Henderson Investors US
Denver,
Colorado
| $199M | -$21.3M | 6 | 0.17% | Reduced |
|
| 35 |
Dimensional Fund Advisors
Austin,
Texas
| $182M | +$2.46M | 8 | 0.11% | Increased |
|
| 36 |
BBA
Baker Bros. Advisors
New York
| $180M | +$19.7M | 10 | 1.9% | Increased |
|
| 37 |
Ameriprise
Minneapolis,
Minnesota
| $179M | -$20.3M | 9 | 0.11% | Reduced |
|
| 38 |
Lazard Asset Management
New York
| $179M | -$4.84M | 4 | 0.39% | Reduced |
|
| 39 |
OrbiMed
New York
| $173M | +$22.8M | 9 | 1.82% | Increased |
|
| 40 |
Parnassus Investments
San Francisco,
California
| $156M | -$6.23M | 1 | 1% | Reduced |
|
| 41 |
EARNEST Partners
Atlanta,
Georgia
| $153M | -$4M | 1 | 1.6% | Reduced |
|
| 42 |
UBS AM
Chicago,
Illinois
| $151M | -$6.09M | 12 | 0.18% | Reduced |
|
| 43 |
Aristotle Capital Management
Los Angeles,
California
| $150M | +$14.2M | 1 | 1.74% | Increased |
|
| 44 |
Acadian Asset Management
Boston,
Massachusetts
| $144M | +$3.78M | 5 | 0.73% | Increased |
|
| 45 |
Boston Partners
Boston,
Massachusetts
| $144M | -$3.05M | 1 | 0.21% | Reduced |
|
| 46 |
JCG
JHL Capital Group
Chicago,
Illinois
| $138M | $0 | 1 | 13.19% | Maintained |
|
| 47 |
Cambiar Investors
Denver,
Colorado
| $137M | +$59.6M | 1 | 1.96% | Increased |
|
| 48 |
ClearBridge Investments
New York
| $135M | -$17.4M | 4 | 0.16% | Reduced |
|
| 49 |
IAM
Iridian Asset Management
Westport,
Connecticut
| $131M | +$12.7M | 1 | 1.11% | Increased |
|
| 50 |
Perceptive Advisors
New York
| $130M | +$27.1M | 13 | 11.37% | Increased |
|